Tetrahydrofuran
eMolecules 1192-30-9 | TETRAHYDROFURFURYL BROMIDE | AstaTech | MFCD00016894 | 165.030 | C5H9BrO | 95.000 | BrCC1CCCO1 | 25g | 449775921
TETRAHYDROFURFURYL BROMIDE | AstaTech | 1192-30-9 | MFCD00016894 | 165.030 | C5H9BrO | 95.000 | BrCC1CCCO1 | 25g | 449775921
Medchemexpress LLC MPT0B392 | 1346169-92-3 | MFCD32174244 | 99.6% | 404.44 | C19H20N2O6S | 50 MG
MPT0B392 is an orally active quinoline-derived microtubule-depolymerizing agent that inhibits tubulin polymerization, activates c-Jun N-terminal kinase (JNK), and induces apoptosis. It is used in cellular assays and preclinical models to study microtubule dynamics and apoptosis signaling pathways.
- Inhibits tubulin polymerization and induces mitotic arrest.
- Activates c-Jun N-terminal kinase (JNK) and promotes apoptosis.
- High purity (99.6%) for reliable experimental results.
- Soluble in DMSO (≈100 mg/mL) for convenient formulation.
- Solid, light yellow appearance for easy inspection.
- Stable as powder at -20°C for up to 3 years.
Sigma Aldrich Fine Chemicals Biosciences 2-Methyltetrahydrofuran Bi
We are committed to bringing you Greener Alternative Products which adhere to one or more of The 12 Principles of Greener Chemistry. This product is a biorenewable and thus aligns with Safer Solvents and Auxiliaries and Use of Renewable feedstocks. Click here for more information.2-Methyltetrahydrofuran is an environmentally favorable alternative to tetrahydrofuran (THf) 1 4 Dioxane (Dioxane) and dichloromethane (DCM) for most industrial applications. Many of its benefits include High boiling pointClean organic-water phase separationReduced energy to recover
AccuStandard, Inc Tetrahydrofuran | 109-99-9 | MFCD00005356 | 5 x 1 mL
Tetrahydrofuran | 1000 µg/mL in Water | MW: 72.106 | 109-99-9 | MFCD00005356 | 5 x 1 mL
eMolecules 121138-01-0 | 3-Iodotetrahydrofuran | Synthonix - Stock | MFCD09878873 | 198.003 | C4H7IO | 95.000 | IC1CCOC1 | 1g | 525918604
3-Iodotetrahydrofuran | Synthonix - Stock | 121138-01-0 | MFCD09878873 | 198.003 | C4H7IO | 95.000 | IC1CCOC1 | 1g | 525918604
Sigma Aldrich Fine Chemicals Biosciences Tetrahydrofuran solution c
The product is a tetrahydrofuran (THF) SOLUTIONon containing 20%(v/v) 1 2-propanediol. THF a saturated cyclic ester is a water miscible organic solvent. The combustion studies of THF have been reported.
Medchemexpress LLC PD-1/PD-L1-IN-23 | 2597056-04-5 | 99.9% | C32H30BrCl2N3O6 | 50 MG
PD-1/PD-L1-IN-23 is a potent and orally active inhibitor of PD-1/PD-L1. It is an ester proagent of L7, a benzo[c]oxadiazole derivative biologically evaluated as an inhibitor of PD-L1. It has shown significant antitumor effects in tumor models of syngeneic and PD-L1 humanized mice.
- Potent and orally active inhibitor of PD-1/PD-L1
- Ester proagent of L7, a benzo[c]oxadiazole derivative
- Displays significant antitumor effects in tumor models
- For research use only
Medchemexpress LLC Eya2 phosphatase inhibitor | 352336-36-8 | 99.4% | 341.36 g/mol | C17H12FN3O2S | 5 MG
MLS000544460 is a research-grade small molecule that selectively and reversibly inhibits the Eya2 phosphatase. It reduces Eya2-mediated cell migration and has reported anti-cancer activity. The compound is supplied as a powder and as DMSO solutions, is characterized by high purity, and is intended for laboratory research use only.
- Selective, reversible inhibition of Eya2 phosphatase.
- Reported Kd ≈ 2.0 μM and IC50 ≈ 4 μM for target engagement.
- High purity (~99.4%) suitable for biochemical and cell-based assays.
- Available as powder and as ready-to-use DMSO solutions.
- Stable when stored under recommended conditions for research reagents.
- Supplied with datasheet, certificate of analysis, and safety data sheet.
Medchemexpress LLC BDP9066 | 2226507-04-4 | 98.2% | 348.44 | 100 MG
BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase (MRCK) inhibitor. It has an IC50 of 64 nM for MRCKβ in SCC12 cells, and Ki values of 0.0136 nM and 0.0233 nM for MRCKα/β respectively (in house determinations). This compound demonstrates a therapeutic effect on skin cancer by reducing substrate phosphorylation.
- Potent and selective MRCK inhibitor.
- Therapeutic effect on skin cancer by reducing substrate phosphorylation.
- Shows antiproliferative effects with greatest activity in hematologic cancer cells.
- Inhibits MLC phosphorylation and blocks SCC12 squamous cell carcinoma motility and invasion.
- Topical application significantly decreases phosphorylated MRCKα S1003 staining and tumor volumes.
Medchemexpress LLC Devazepide | 103420-77-5 | MFCD00864500 | ≥98.0% | 408.45 | C25H20N4O2 | 50 MG
Devazepide is an analytical reference standard of a selective cholecystokinin (CCK) receptor antagonist intended for research and assay use. It is supplied as a high-purity solid and is offered in multiple pack sizes, including a 50 mg vial. Specification details and a certificate of analysis are provided for analytical applications.
- Analytical/reference standard suitable for assay and research applications.
- Selective cholecystokinin (CCK) receptor antagonist.
- CAS 103420-77-5.
- Molecular formula C25H20N4O2; molecular weight 408.45.
- Purity ≥98.0% (HPLC).
- Available in multiple pack sizes, including 50 mg.
- Certificate of analysis and storage instructions provided.
Medchemexpress LLC Vebicorvir | 2090064-66-5 | 99.7% | 467.44 | 50 MG
Vebicorvir is a first-generation inhibitor of the hepatitis B virus (HBV) core protein. It effectively suppresses the formation of covalently closed circular DNA (cccDNA) in de novo infection models, with EC50 values ranging from 1.84 μM to 7.3 μM. This compound inhibits pgRNA, HBeAg, and HBsAg production.
- First-generation hepatitis B virus (HBV) core protein inhibitor.
- Suppresses cccDNA formation in de novo infection models.
- Inhibits pgRNA, HBeAg, and HBsAg production.
Medchemexpress LLC Linzagolix | 935283-04-8 | 99.68% | 508.42 | 100 MG
Linzagolix is a potent, non-peptide, and orally active GnRH antagonist. It can be used for research related to uterine fibroids, endometriosis, and adenomyosis.
- Potent, non-peptide, and orally active GnRH antagonist.
- Can be used for uterine fibroids, endometriosis, and adenomyosis research.
- Reduces cyst volume in a rat model of endometriosis.
- Suppresses hypothalamic-pituitary-gonadal function by reducing serum luteinizing hormone and testosterone levels.
Medchemexpress LLC GSK3182571 | 2135595-04-7 | 99.8% | 495.02 g/mol | C25H31ClN8O | 100MG
GSK3182571 is a small-molecule pan-kinase inhibitor for research use that modulates Akt signaling and the PI3K/Akt/mTOR pathway. It is provided as a 100 mg research sample intended for in vitro pharmacology and biochemical studies, including probing kinase networks and off-target effects in cellular models. The compound is typically stored at -20°C and is soluble in DMSO.
- Pan-kinase inhibitor active against Akt and related kinases.
- High purity suitable for research assays.
- Molecular formula C25H31ClN8O; molecular weight 495.02 g/mol.
- Soluble in DMSO for assay preparation.
- Intended for in vitro pharmacology and biochemical studies.
- Store at -20°C to maintain stability.
- Supplied as a 100 mg research sample.
Medchemexpress LLC Metsulfuron-methyl (Standard) | 74223-64-6 | 50 MG
Metsulfuron-methyl (Standard) is the analytical standard of Metsulfuron-methyl. This product is intended for research and analytical applications. Metsulfuron-methyl is a systemic sulfonylurea herbicide that has been widely used to control broadleaf weeds and annual grasses in rice, corn, wheat, and barley. Metsulfuron-methyl exhibits high herbicidal activity and low mammalian toxicity, with an LD50 for rats exceeding 5000 mg/kg.
- The compound is the grade of analytical standard, which is the reference standard supplied assay.
- It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Medchemexpress LLC Ecliptasaponin D | 206756-04-9 | 5 MG
Ecliptasaponin D is a triterpenoid glucoside isolated from Eclipta alba (L.) Hassk, which is the aerial part of Eclipta prostrate. Eclipta prostrate is considered a nourishing herbal medicine with pleiotropic effects, including anti-inflammatory, hepatoprotective, antioxidant, and immunomodulatory properties.
- Triterpenoid glucoside
- Isolated from Eclipta alba (L.) Hassk
- Anti-inflammatory properties
- Hepatoprotective properties
- Antioxidant properties
- Immunomodulatory properties